01 7Coniel
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2020 Revenue in Millions : 30
2019 Revenue in Millions : 38
Growth (%) : -20
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2021 Revenue in Millions : 23
2020 Revenue in Millions : 30
Growth (%) : -16
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 15
2021 Revenue in Millions : 23
Growth (%) : -34
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 10
2022 Revenue in Millions : 15
Growth (%) : -25
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2017 Revenue in Millions : 60
2016 Revenue in Millions : 73
Growth (%) : -17
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2018 Revenue in Millions : 43
2017 Revenue in Millions : 57
Growth (%) : -24%
Main Therapeutic Indication : Cardiovascular Diseases
Currency : USD
2019 Revenue in Millions : 37
2018 Revenue in Millions : 45
Growth (%) : -17
LOOKING FOR A SUPPLIER?